The immunochemical specificity of the observed cross-reactivity between Escherichia coli strain 101 and Staphylococcus aureus strain Mardi was examined. The cross-reactivity was shown to be dependent upon mucopeptide antibodies which are present in normal and immune sera. Although both organisms contained surface antigens with immunodominant glucuronic acid residues, in vitro phagocytosis studies indicated that antibodies directed against these antigens were not significantly involved in the opsonization process. Rather, antibodies with mucopeptide specificity were shown to be involved in the in vitro phagocytosis of these organisms by polymorphonuclear leukocytes. The mucopeptide antibodies, which were found in both nonimmune and immune sera, were shown to be effective in opsonizing both the S. aureus strain and the E. coli strain. The ubiquitous distribution of E. coli strains containing mucopeptide antigens common to most bacteria suggests that these organisms may be responsible for the wide prevalence of natural staphylococcal opsonins with mucopeptide specificity in normal sera.
There is substantial evidence to indicate that nonimmune animal and human sera contain opsonins or natural antibodies which can readily initiate the opsonization of Staphylococcus aureus (6, 15, 19, 22) . The wide prevalence of these opsonins, especially in young, normal experimental animals, cannot entirely be explained on the basis of natural immunization with homologous organisms. Rather, this acquisition of natural antibodies may be due to antigenic stimulation by the ubiquitous enteric bacteria possessing cross-reactive antigens. There are several examples of serological cross-reactivity between the enteric bacteria and S. aureus strains. The observed cross-reaction between Escherichia coli strain 075:KlOO:H5 and S. aureus strain Copenhagen was suggested to be due to ribitol moieties found in the K-antigen of the E. coli strain and in the cell wall teichoic acid of the S. aureus strain (20) . Recently, an immunological cross-reaction between E. coli strain 101 and S. aureus strain Mardi, which possesses an antiphagocytic surface antigen consisting of immunodominant D-glucuronic acid residues, was observed; however, the immunochemical specificity of this cross-reactivity was not determined (14) .
This study describes the immunochemical basis for the cross-reactivity between E. coli strain 101 Karakawa and Young (14, 21) . Leukocytes were prepared by the method of Karakawa and Young (14) . Specific mucopeptide antibodies were obtained from mucopeptideantibody complexes by the method of Braun and Krause (2) . The agglutination tests were performed by the method of Karakawa et al. (11) . Absorption of antisera by the mucopeptide preparation was previously described (11) .
RESULTS
Previous studies have shown that S. aureus strain Mardi, which possesses a polymer consisting of galactose and immunodominant D-glucuronic acid residues, cross-reacts with an E. coli isolated from a severe case of calf gastroenteritis, provisionally designated strain 101 by Glantz (14) . Represented in Fig. 1 (14) .
Illustrated in Table 1 (16, 24) .
b Total hexuronic acid as described by Davidson (4) . c Determined by the method of Kesler (16) .
VOL. 25, 1979 on October 27, 2017 by guest http://iai.asm.org/ Downloaded from results suggest that the hexuronic acid moiety of the native polymer may be glucuronic acid, which on reduction forms the corresponding glucose. Quantitative precipitin inhibition studies employing a series of monosaccharide inhibitors indicated that a 2% solution of D-glucuronic acid inhibited approximately 50% of the quantitative precipitin reaction between the E. coli polymer and homologous antiserum, whereas mannose, glucose, galactose, glucosamine, and galactosamine in the same concentration were ineffective as inhibitors. Although both E. coli strain 101 and S. aureus strain Mardi possess surface antigens consisting ofimmunodominant glucuronic acid residues, precipitin analyses employing purified strain Mardi and strain 101 carbohydrates and homologous and heterologous antisera failed to reveal a cross-reactivity. In addition, no appreciable inhibitory effect was observed when either of the purified polysaccharides was used to inhibit the in vitro phagocytosis of the homologous organisms by polymorphonuclear leukocytes (PMN) in the presence of homologous and heterologous antisera. Staphylococcal ribitol teichoic acid was also shown to be ineffective in inhibiting the in vitro phagocytosis of S. aureus strain Mardi in the presence of normal or immune sera. These results suggest that the cross-reactivity between E. coli strain 101 and S. aureus strain Mardi may not be due to the surface antigens, but rather to another common cross-reactive antigen.
Immunochemical specificity of the observed cross-reactivity. Despite the fact that these two strains possess sufficient quantities of surface antigens, agglutination studies indicated that both strain Mardi and strain 101 did have mucopeptide moieties which were available for binding by mucopeptide antibodies. Illustrated in Table 2 are the agglutination results of the cross-reactivity between E. coli strain 101 and S. aureus strain Mardi. Agglutinins against S.
aureues strain Mardi and E. coli strain 101 were noticeably absent in the normal control serum. In the presence of immune sera, staphylococcal cell suspensions gave a titer of 1,280 with the homologous serum and heterologous titer of 20 against anti-E. coli serum. In contrast, E. coli cell suspensions gave a titer of 640 with homologous serum and 80 with anti-staphylococcal serum. Although a cross-reactivity between E. coli and staphylococci was observed, it appeared to be weak. However, when the cell preparations were boiled in pH 7.0 buffer for 1 hour and subsequently washed to remove the acidic surface antigens, the degree of heterologous crossreactivity was elevated, as shown in Table 2 . The treated cell suspensions which were now INFECT. IMMUN. devoid of much of the surface acidic antigen in both instances gave a titer of 160 with the heterologous antisera. These results indicated that the immunological cross-reactivity observed between E. coli strain 101 and S. aureus strain Mardi could be due to common moieties of the mucopeptide antigen. Depicted in Fig. 2A are the results of the interaction between S. aureus strain Mardi and PMN in the presence of heterologous anti-E. coli serum. In this test, E. coli antiserum was shown to contain appreciable levels of opsonins directed against S. aureus strain Mardi. After subsequent absorption with a purified staphylococcal mucopeptide preparation, all of the available opsonins against strain Mardi (19) . Importance of natural antibodies in nonimmune sera. It has been suggested by many investigators that natural antibodies are quite prevalent in nonimmune and animal sera (6, 22) . In this laboratory, many "normal" sera derived from experimental animals and humans were examined for the presence of opsonins directed against staphylococci and E. coli. Illustrated in Fig. 4 are the results of a typical opsonization profile of some of the representative normal animal sera. It should be noted that fetal calf serum and selected normal rabbit serum contained only minimal levels of opsonins against either S. aureus strain Mardi or E. coli strain 101. On the other hand, all of the human, bovine, and porcine normal sera tested contained opsonins against both strains Mardi and 101. Absorption of these antisera with staphylococcal or E. coli mucopeptide indicated that the opsonins present in these nonimmune sera were directed against bacterial mucopeptide. As shown in Fig.  5 , essentially all of the opsonic capacity of the bovine and porcine normal sera was removed by absorption with purified mucopeptide. Although the opsonic capacity of the human sera was reduced by mucopeptide absorption, it still had a small amount of opsonic activity. This could be attributed to the fact that human sera may contain minimal levels of opsonins directed against the surface antigens of strains Mardi and 101. These results suggested a widespread prevalence of opsonins directed against the common moieties of bacterial mucopeptide. The presence of these antibodies in normal sera could be due to a continued low-level antigenic stimulation by ubiquitous bacteria, namely E. coli. With such a widespread prevalence of mucopeptide opsonins, it is possible that they may play a much greater role in the pathogenesis of staphylococcal infections than previously suspected. antigen of Haemophilus influenza can be sighum<-m nificantly increased after immunization with E. coli, S. aureus, and Bacillus pumilus, all of which carry a ribitol cross-reactive antigen (20) . These investigators suggested that the presence loo '-j20 of these antibodies in normal human sera may be the result of continued stimulation by crossMardi and reactive antigens of heterologous bacteria. bovine, porIt should be noted that in the cross-reactivity * absorption between S. aureus strain Mardi and E. coli strain 101, the antiphagocytic surface antigens are prominent features of both organisms and therefore can mask the mucopeptide matrix. For cross-reac-example, Howard and Glynn have shown that ts of E. coli the acidic K-antigen of E. coli can mask the Li was stud-mucopeptide matrix (8) (19) . Since many previous studies em-S aureus ployed strains maintained on laboratory media, sess an an-these organisms often represented variants lactose and which were lean in surface antigens and there-
